Hdfc Pharma And Healthcare Fund Overview
Category Pharma Fund
BMSMONEY Rank N/A
BMSMONEY Rating N/A
Gro. Opt. As On: 20-01-2025
NAV ₹16.29(R) +0.91% ₹16.56(D) +0.92%
Returns 1Y 3Y 5Y 7Y 10Y
LumpSum (R) 39.35% -% -% -% -%
LumpSum (D) 41.11% -% -% -% -%
SIP (R) -1.4% -% -% -% -%
SIP (D) -0.03% -% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
Top Pharma Fund
Fund Name Rank Rating
Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
Sbi Healthcare Opportunities Fund -
Tata India Pharma & Healthcare Fund -
Uti Healthcare Fund -
- -

NAV Date: 20-01-2025

Scheme Name NAV Rupee Change Percent Change
HDFC Pharma and Healthcare Fund - IDCW Option 16.29
0.1500
0.9100%
HDFC Pharma and Healthcare Fund - Growth Option 16.29
0.1500
0.9100%
HDFC Pharma and Healthcare Fund - IDCW Option - Direct Plan 16.56
0.1500
0.9200%
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan 16.56
0.1500
0.9200%

Review Date: 20-01-2025

A review of the different performance parameters of the fund is as follows:
  1. Returns: It indicates the appreciation in the investment's value within the investment period, represented as a percentage or a specific amount of money. We conducted an analysis of the four return parameters of this fund to assess their performance. To assess performance, we have segmented the return parameters into three groups: the top 25%, parameters below the top 25% but still above average, and parameters below average. The results are provided below.
    1. Top 25%: Four return parameters of the HDFC Pharma And Healthcare Fund are in the top 25% in the category, as shown below:
      • 1M Return %
      • 3M Return %
      • 6M Return %
      • 1Y Return %
    2. Above Average Below the Top 25%: The fund does not have any return parameter which is above average but below the top 25%.
    3. Below Average: HDFC Pharma And Healthcare Fund has no return parameters that are below average in the category.
  2. Risk: The threat of not realizing projected profits or even facing financial loss due to different issues is known as risk. For HDFC Pharma And Healthcare Fund, we have analyzed zero risk parameters and divided them into three groups the lowest 25%, below average but above the lowest 25%, and above average, which are described below.
    1. Lowest 25%: HDFC Pharma And Healthcare Fund does not have any risk parameters in the lowest 25% of the category. It means high risk compared to other funds in the category.
    2. Below Average but Above the Lowest 25%: HDFC Pharma And Healthcare Fund does not have any risk parameters in the below average but above the lowest 25% of the category.
    3. Above Average: HDFC Pharma And Healthcare Fund does not have any risk parameters above average; which is a good sign.
  3. Risk Adjusted Performance Parameters: In mutual funds, risk-adjusted performance parameters are evaluation tools that gauge the returns of an investment against the risk taken. They assist investors in comparing various investments, factoring in both risk and returns. We have evaluated zero risk-adjusted performance parameters of the fund.
    1. Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the top 25% of the category.
    2. Above Average Below Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.
    3. Below Average Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.


Not able to see in mobile!!! save the chart by clicking on camera icon.

KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -0.96
-1.74
-2.69 | -0.23 2 | 12 Very Good
3M Return % 0.84
-2.05
-8.37 | 1.62 2 | 12 Very Good
6M Return % 18.60
11.49
-0.84 | 19.71 2 | 12 Very Good
1Y Return % 39.35
29.29
17.54 | 39.35 1 | 11 Very Good
1Y SIP Return % -1.40
-12.07
-23.57 | -1.40 1 | 11 Very Good
Return data last Updated On : Jan. 20, 2025.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Dec. 31, 2024
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -0.86 -1.63 -2.59 | -0.09 2 | 12
3M Return % 1.15 -1.73 -7.99 | 2.06 2 | 12
6M Return % 19.33 12.22 -0.01 | 20.73 2 | 12
1Y Return % 41.11 30.94 19.49 | 41.11 1 | 11
1Y SIP Return % -0.03 -10.83 -22.11 | -0.03 1 | 11
Return data last Updated On : Jan. 20, 2025.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Dec. 31, 2024
KPIs: Key Performance Indicators

Investment Period Regular Direct
Return % Current Value of ₹ 10000 Return % Current Value of ₹ 10000
1D 0.91 ₹ 10,091.00 0.92 ₹ 10,092.00
1W 1.51 ₹ 10,151.00 1.53 ₹ 10,153.00
1M -0.96 ₹ 9,904.00 -0.86 ₹ 9,914.00
3M 0.84 ₹ 10,084.00 1.15 ₹ 10,115.00
6M 18.60 ₹ 11,860.00 19.33 ₹ 11,933.00
1Y 39.35 ₹ 13,935.00 41.11 ₹ 14,111.00
3Y ₹ ₹
5Y ₹ ₹
7Y ₹ ₹
10Y ₹ ₹
15Y ₹ ₹

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.

Investment Period Invested Amount Regular Direct
XIRR % Current Value of Invested Amount XIRR % Current Value of Invested Amount
1Y ₹ 12000 -1.40 ₹ 11,908.61 -0.03 ₹ 11,997.79
3Y ₹ 36000 ₹ ₹
5Y ₹ 60000 ₹ ₹
7Y ₹ 84000 ₹ ₹
10Y ₹ 120000 ₹ ₹
15Y ₹ 180000 ₹ ₹


Date Hdfc Pharma And Healthcare Fund NAV Regular Growth Hdfc Pharma And Healthcare Fund NAV Direct Growth
20-01-2025 16.293 16.556
17-01-2025 16.146 16.405
16-01-2025 16.092 16.35
15-01-2025 16.081 16.338
14-01-2025 16.246 16.505
13-01-2025 16.05 16.306
10-01-2025 16.463 16.724
09-01-2025 16.822 17.087
08-01-2025 16.983 17.25
07-01-2025 17.107 17.376
06-01-2025 16.906 17.171
03-01-2025 17.106 17.372
02-01-2025 17.155 17.421
01-01-2025 17.087 17.352
31-12-2024 17.023 17.286
30-12-2024 16.96 17.222
27-12-2024 16.782 17.04
26-12-2024 16.621 16.876
24-12-2024 16.538 16.789
23-12-2024 16.487 16.737
20-12-2024 16.451 16.7

Fund Launch Date: 04/Oct/2023
Fund Category: Pharma Fund
Investment Objective: To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
Fund Description: An open-ended equity scheme investing in Pharma and healthcare companies
Fund Benchmark: BSE Healthcare Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.